<SEC-DOCUMENT>0001950047-23-006132-index.html : 20231215
<SEC-HEADER>0001950047-23-006132.hdr.sgml : 20231215
<ACCEPTANCE-DATETIME>20231215162212
ACCESSION NUMBER:		0001950047-23-006132
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20231215
DATE AS OF CHANGE:		20231215

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CymaBay Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001042074
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				943103561
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-36500
		FILM NUMBER:		231490662

	BUSINESS ADDRESS:	
		STREET 1:		7575 GATEWAY BOULEVARD
		STREET 2:		SUITE 110
		CITY:			NEWARK
		STATE:			CA
		ZIP:			94560
		BUSINESS PHONE:		510-293-8800

	MAIL ADDRESS:	
		STREET 1:		7575 GATEWAY BOULEVARD
		STREET 2:		SUITE 110
		CITY:			NEWARK
		STATE:			CA
		ZIP:			94560

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	METABOLEX, INC.
		DATE OF NAME CHANGE:	20090721

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	METABOLEX INC
		DATE OF NAME CHANGE:	19970710

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Quinlan Paul T
		CENTRAL INDEX KEY:			0001333277

	FILING VALUES:
		FORM TYPE:		144

	BUSINESS ADDRESS:	
		BUSINESS PHONE:		510-293-8123

	MAIL ADDRESS:	
		STREET 1:		C/O CYMABAY THERAPEUTICS, INC.
		STREET 2:		7575 GATEWAY BLVD., SUITE 110
		CITY:			NEWARK
		STATE:			CA
		ZIP:			94560
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>